Todd Bradley Selected Research

Todd Bradley Research Topics

14	Infections 03/2024 - 04/2016
8	COVID-19 03/2024 - 01/2021
3	Virus Diseases (Viral Diseases) 03/2024 - 01/2021
3	Neoplasms (Cancer) 01/2022 - 01/2020
2	Inflammation (Inflammations) 03/2024 - 09/2023
1	Viremia 11/2023
1	Coinfection 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Liver Diseases (Liver Disease) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 12/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2007

9	VaccinesIBA 01/2023 - 11/2017
5	AntibodiesIBA 01/2022 - 02/2007
4	Proteins (Proteins, Gene)FDA Link 10/2018 - 02/2007
3	EpitopesIBA 01/2022 - 04/2016
3	Broadly Neutralizing AntibodiesIBA 01/2021 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 03/2024 - 09/2023
2	ChemokinesIBA 03/2024 - 09/2023
2	CytokinesIBA 03/2024 - 09/2023
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 09/2023
2	AutoantibodiesIBA 03/2024 - 09/2023
2	EnzymesIBA 03/2024 - 09/2023
2	BNT162 VaccineIBA 01/2022 - 01/2021
2	COVID-19 VaccinesIBA 02/2021 - 01/2021
1	Angiotensin-Converting Enzyme 2IBA 09/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	mRNA VaccinesIBA 11/2022
1	Neutralizing AntibodiesIBA 11/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	AerosolsIBA 10/2018
1	AIDS VaccinesIBA 10/2018
1	Immunoglobulin A (IgA)IBA 10/2018
1	Immunoglobulin G (IgG)IBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Combined VaccinesIBA 01/2017
1	AutoantigensIBA 02/2007
1	Antinuclear AntibodiesIBA 02/2007